世界のCAR-T細胞免疫療法市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global CAR T-Cell Immunotherapy Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-3967
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、123ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、CAR-T細胞免疫療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（単剤療法、併用療法）、用途別市場規模（血液悪性腫瘍、固形悪性腫瘍）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・CAR-T細胞免疫療法の市場動向
・企業の競争状況、市場シェア
・CAR-T細胞免疫療法の種類別市場規模と予測2016-2027（単剤療法、併用療法）
・CAR-T細胞免疫療法の用途別市場規模と予測2016-2027（血液悪性腫瘍、固形悪性腫瘍）
・CAR-T細胞免疫療法の北米市場規模2016-2027（アメリカ、カナダ）
・CAR-T細胞免疫療法の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・CAR-T細胞免疫療法のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・CAR-T細胞免疫療法の中南米市場規模2016-2027（メキシコ、ブラジル）
・CAR-T細胞免疫療法の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（AbbVie、Celgene、Kite Pharma、Oxford BioMedica、Novartis、Gilead、Pfizer、Cellectis、Bellicum、Mustang Bio、CARsgen Therapeutics、Xyphos、Minerva Biotechnologies、Adaptimmune、Ziopharm Oncology、Aurora Biopharma、Creative Biolabs）
・結論

CAR T-Cell Immunotherapy is a new type of cancer treatment. This emerging treatment represents one of the biggest breakthroughs since the introduction of chemotherapy. T cells is a type of white blood cell extracted from the patient’s blood by doctors, and added an artificial receptor to their surface. When infused into a patient, the cells get multiplied and stay in the body as “living drugs” and help in detecting and fighting cancer. CAR-T cell therapy is defined as a type of immunotherapy that teaches T cells to recognize and destroy cancer.

Market Analysis and Insights: Global CAR T-Cell Immunotherapy Market
The global CAR T-Cell Immunotherapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global CAR T-Cell Immunotherapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global CAR T-Cell Immunotherapy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global CAR T-Cell Immunotherapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global CAR T-Cell Immunotherapy market.

Global CAR T-Cell Immunotherapy Scope and Market Size
CAR T-Cell Immunotherapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global CAR T-Cell Immunotherapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Monotherapy
Combination Therapy

Segment by Application
Hematologic Malignancies
Solid Malignancies

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AbbVie
Celgene
Kite Pharma
Oxford BioMedica
Novartis
Gilead
Pfizer
Cellectis
Bellicum
Mustang Bio
CARsgen Therapeutics
Xyphos
Minerva Biotechnologies
Adaptimmune
Ziopharm Oncology
Aurora Biopharma
Creative Biolabs

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CAR T-Cell Immunotherapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Monotherapy
1.2.3 Combination Therapy
1.3 Market by Application
1.3.1 Global CAR T-Cell Immunotherapy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hematologic Malignancies
1.3.3 Solid Malignancies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global CAR T-Cell Immunotherapy Market Perspective (2016-2027)
2.2 CAR T-Cell Immunotherapy Growth Trends by Regions
2.2.1 CAR T-Cell Immunotherapy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 CAR T-Cell Immunotherapy Historic Market Share by Regions (2016-2021)
2.2.3 CAR T-Cell Immunotherapy Forecasted Market Size by Regions (2022-2027)
2.3 CAR T-Cell Immunotherapy Industry Dynamic
2.3.1 CAR T-Cell Immunotherapy Market Trends
2.3.2 CAR T-Cell Immunotherapy Market Drivers
2.3.3 CAR T-Cell Immunotherapy Market Challenges
2.3.4 CAR T-Cell Immunotherapy Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top CAR T-Cell Immunotherapy Players by Revenue
3.1.1 Global Top CAR T-Cell Immunotherapy Players by Revenue (2016-2021)
3.1.2 Global CAR T-Cell Immunotherapy Revenue Market Share by Players (2016-2021)
3.2 Global CAR T-Cell Immunotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by CAR T-Cell Immunotherapy Revenue
3.4 Global CAR T-Cell Immunotherapy Market Concentration Ratio
3.4.1 Global CAR T-Cell Immunotherapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CAR T-Cell Immunotherapy Revenue in 2020
3.5 CAR T-Cell Immunotherapy Key Players Head office and Area Served
3.6 Key Players CAR T-Cell Immunotherapy Product Solution and Service
3.7 Date of Enter into CAR T-Cell Immunotherapy Market
3.8 Mergers & Acquisitions, Expansion Plans

4 CAR T-Cell Immunotherapy Breakdown Data by Type
4.1 Global CAR T-Cell Immunotherapy Historic Market Size by Type (2016-2021)
4.2 Global CAR T-Cell Immunotherapy Forecasted Market Size by Type (2022-2027)

5 CAR T-Cell Immunotherapy Breakdown Data by Application
5.1 Global CAR T-Cell Immunotherapy Historic Market Size by Application (2016-2021)
5.2 Global CAR T-Cell Immunotherapy Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America CAR T-Cell Immunotherapy Market Size (2016-2027)
6.2 North America CAR T-Cell Immunotherapy Market Size by Type
6.2.1 North America CAR T-Cell Immunotherapy Market Size by Type (2016-2021)
6.2.2 North America CAR T-Cell Immunotherapy Market Size by Type (2022-2027)
6.2.3 North America CAR T-Cell Immunotherapy Market Size by Type (2016-2027)
6.3 North America CAR T-Cell Immunotherapy Market Size by Application
6.3.1 North America CAR T-Cell Immunotherapy Market Size by Application (2016-2021)
6.3.2 North America CAR T-Cell Immunotherapy Market Size by Application (2022-2027)
6.3.3 North America CAR T-Cell Immunotherapy Market Size by Application (2016-2027)
6.4 North America CAR T-Cell Immunotherapy Market Size by Country
6.4.1 North America CAR T-Cell Immunotherapy Market Size by Country (2016-2021)
6.4.2 North America CAR T-Cell Immunotherapy Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe CAR T-Cell Immunotherapy Market Size (2016-2027)
7.2 Europe CAR T-Cell Immunotherapy Market Size by Type
7.2.1 Europe CAR T-Cell Immunotherapy Market Size by Type (2016-2021)
7.2.2 Europe CAR T-Cell Immunotherapy Market Size by Type (2022-2027)
7.2.3 Europe CAR T-Cell Immunotherapy Market Size by Type (2016-2027)
7.3 Europe CAR T-Cell Immunotherapy Market Size by Application
7.3.1 Europe CAR T-Cell Immunotherapy Market Size by Application (2016-2021)
7.3.2 Europe CAR T-Cell Immunotherapy Market Size by Application (2022-2027)
7.3.3 Europe CAR T-Cell Immunotherapy Market Size by Application (2016-2027)
7.4 Europe CAR T-Cell Immunotherapy Market Size by Country
7.4.1 Europe CAR T-Cell Immunotherapy Market Size by Country (2016-2021)
7.4.2 Europe CAR T-Cell Immunotherapy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific CAR T-Cell Immunotherapy Market Size (2016-2027)
8.2 Asia-Pacific CAR T-Cell Immunotherapy Market Size by Type
8.2.1 Asia-Pacific CAR T-Cell Immunotherapy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific CAR T-Cell Immunotherapy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific CAR T-Cell Immunotherapy Market Size by Type (2016-2027)
8.3 Asia-Pacific CAR T-Cell Immunotherapy Market Size by Application
8.3.1 Asia-Pacific CAR T-Cell Immunotherapy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific CAR T-Cell Immunotherapy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific CAR T-Cell Immunotherapy Market Size by Application (2016-2027)
8.4 Asia-Pacific CAR T-Cell Immunotherapy Market Size by Region
8.4.1 Asia-Pacific CAR T-Cell Immunotherapy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific CAR T-Cell Immunotherapy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America CAR T-Cell Immunotherapy Market Size (2016-2027)
9.2 Latin America CAR T-Cell Immunotherapy Market Size by Type
9.2.1 Latin America CAR T-Cell Immunotherapy Market Size by Type (2016-2021)
9.2.2 Latin America CAR T-Cell Immunotherapy Market Size by Type (2022-2027)
9.2.3 Latin America CAR T-Cell Immunotherapy Market Size by Type (2016-2027)
9.3 Latin America CAR T-Cell Immunotherapy Market Size by Application
9.3.1 Latin America CAR T-Cell Immunotherapy Market Size by Application (2016-2021)
9.3.2 Latin America CAR T-Cell Immunotherapy Market Size by Application (2022-2027)
9.3.3 Latin America CAR T-Cell Immunotherapy Market Size by Application (2016-2027)
9.4 Latin America CAR T-Cell Immunotherapy Market Size by Country
9.4.1 Latin America CAR T-Cell Immunotherapy Market Size by Country (2016-2021)
9.4.2 Latin America CAR T-Cell Immunotherapy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa CAR T-Cell Immunotherapy Market Size (2016-2027)
10.2 Middle East & Africa CAR T-Cell Immunotherapy Market Size by Type
10.2.1 Middle East & Africa CAR T-Cell Immunotherapy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa CAR T-Cell Immunotherapy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa CAR T-Cell Immunotherapy Market Size by Type (2016-2027)
10.3 Middle East & Africa CAR T-Cell Immunotherapy Market Size by Application
10.3.1 Middle East & Africa CAR T-Cell Immunotherapy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa CAR T-Cell Immunotherapy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa CAR T-Cell Immunotherapy Market Size by Application (2016-2027)
10.4 Middle East & Africa CAR T-Cell Immunotherapy Market Size by Country
10.4.1 Middle East & Africa CAR T-Cell Immunotherapy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa CAR T-Cell Immunotherapy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 AbbVie Business Overview
11.1.3 AbbVie CAR T-Cell Immunotherapy Introduction
11.1.4 AbbVie Revenue in CAR T-Cell Immunotherapy Business (2016-2021)
11.1.5 AbbVie Recent Development
11.2 Celgene
11.2.1 Celgene Company Details
11.2.2 Celgene Business Overview
11.2.3 Celgene CAR T-Cell Immunotherapy Introduction
11.2.4 Celgene Revenue in CAR T-Cell Immunotherapy Business (2016-2021)
11.2.5 Celgene Recent Development
11.3 Kite Pharma
11.3.1 Kite Pharma Company Details
11.3.2 Kite Pharma Business Overview
11.3.3 Kite Pharma CAR T-Cell Immunotherapy Introduction
11.3.4 Kite Pharma Revenue in CAR T-Cell Immunotherapy Business (2016-2021)
11.3.5 Kite Pharma Recent Development
11.4 Oxford BioMedica
11.4.1 Oxford BioMedica Company Details
11.4.2 Oxford BioMedica Business Overview
11.4.3 Oxford BioMedica CAR T-Cell Immunotherapy Introduction
11.4.4 Oxford BioMedica Revenue in CAR T-Cell Immunotherapy Business (2016-2021)
11.4.5 Oxford BioMedica Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis CAR T-Cell Immunotherapy Introduction
11.5.4 Novartis Revenue in CAR T-Cell Immunotherapy Business (2016-2021)
11.5.5 Novartis Recent Development
11.6 Gilead
11.6.1 Gilead Company Details
11.6.2 Gilead Business Overview
11.6.3 Gilead CAR T-Cell Immunotherapy Introduction
11.6.4 Gilead Revenue in CAR T-Cell Immunotherapy Business (2016-2021)
11.6.5 Gilead Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer CAR T-Cell Immunotherapy Introduction
11.7.4 Pfizer Revenue in CAR T-Cell Immunotherapy Business (2016-2021)
11.7.5 Pfizer Recent Development
11.8 Cellectis
11.8.1 Cellectis Company Details
11.8.2 Cellectis Business Overview
11.8.3 Cellectis CAR T-Cell Immunotherapy Introduction
11.8.4 Cellectis Revenue in CAR T-Cell Immunotherapy Business (2016-2021)
11.8.5 Cellectis Recent Development
11.9 Bellicum
11.9.1 Bellicum Company Details
11.9.2 Bellicum Business Overview
11.9.3 Bellicum CAR T-Cell Immunotherapy Introduction
11.9.4 Bellicum Revenue in CAR T-Cell Immunotherapy Business (2016-2021)
11.9.5 Bellicum Recent Development
11.10 Mustang Bio
11.10.1 Mustang Bio Company Details
11.10.2 Mustang Bio Business Overview
11.10.3 Mustang Bio CAR T-Cell Immunotherapy Introduction
11.10.4 Mustang Bio Revenue in CAR T-Cell Immunotherapy Business (2016-2021)
11.10.5 Mustang Bio Recent Development
11.11 CARsgen Therapeutics
11.11.1 CARsgen Therapeutics Company Details
11.11.2 CARsgen Therapeutics Business Overview
11.11.3 CARsgen Therapeutics CAR T-Cell Immunotherapy Introduction
11.11.4 CARsgen Therapeutics Revenue in CAR T-Cell Immunotherapy Business (2016-2021)
11.11.5 CARsgen Therapeutics Recent Development
11.12 Xyphos
11.12.1 Xyphos Company Details
11.12.2 Xyphos Business Overview
11.12.3 Xyphos CAR T-Cell Immunotherapy Introduction
11.12.4 Xyphos Revenue in CAR T-Cell Immunotherapy Business (2016-2021)
11.12.5 Xyphos Recent Development
11.13 Minerva Biotechnologies
11.13.1 Minerva Biotechnologies Company Details
11.13.2 Minerva Biotechnologies Business Overview
11.13.3 Minerva Biotechnologies CAR T-Cell Immunotherapy Introduction
11.13.4 Minerva Biotechnologies Revenue in CAR T-Cell Immunotherapy Business (2016-2021)
11.13.5 Minerva Biotechnologies Recent Development
11.14 Adaptimmune
11.14.1 Adaptimmune Company Details
11.14.2 Adaptimmune Business Overview
11.14.3 Adaptimmune CAR T-Cell Immunotherapy Introduction
11.14.4 Adaptimmune Revenue in CAR T-Cell Immunotherapy Business (2016-2021)
11.14.5 Adaptimmune Recent Development
11.15 Ziopharm Oncology
11.15.1 Ziopharm Oncology Company Details
11.15.2 Ziopharm Oncology Business Overview
11.15.3 Ziopharm Oncology CAR T-Cell Immunotherapy Introduction
11.15.4 Ziopharm Oncology Revenue in CAR T-Cell Immunotherapy Business (2016-2021)
11.15.5 Ziopharm Oncology Recent Development
11.16 Aurora Biopharma
11.16.1 Aurora Biopharma Company Details
11.16.2 Aurora Biopharma Business Overview
11.16.3 Aurora Biopharma CAR T-Cell Immunotherapy Introduction
11.16.4 Aurora Biopharma Revenue in CAR T-Cell Immunotherapy Business (2016-2021)
11.16.5 Aurora Biopharma Recent Development
11.17 Creative Biolabs
11.17.1 Creative Biolabs Company Details
11.17.2 Creative Biolabs Business Overview
11.17.3 Creative Biolabs CAR T-Cell Immunotherapy Introduction
11.17.4 Creative Biolabs Revenue in CAR T-Cell Immunotherapy Business (2016-2021)
11.17.5 Creative Biolabs Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global CAR T-Cell Immunotherapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Monotherapy
Table 3. Key Players of Combination Therapy
Table 4. Global CAR T-Cell Immunotherapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global CAR T-Cell Immunotherapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global CAR T-Cell Immunotherapy Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global CAR T-Cell Immunotherapy Market Share by Regions (2016-2021)
Table 8. Global CAR T-Cell Immunotherapy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global CAR T-Cell Immunotherapy Market Share by Regions (2022-2027)
Table 10. CAR T-Cell Immunotherapy Market Trends
Table 11. CAR T-Cell Immunotherapy Market Drivers
Table 12. CAR T-Cell Immunotherapy Market Challenges
Table 13. CAR T-Cell Immunotherapy Market Restraints
Table 14. Global CAR T-Cell Immunotherapy Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global CAR T-Cell Immunotherapy Market Share by Players (2016-2021)
Table 16. Global Top CAR T-Cell Immunotherapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CAR T-Cell Immunotherapy as of 2020)
Table 17. Ranking of Global Top CAR T-Cell Immunotherapy Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by CAR T-Cell Immunotherapy Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players CAR T-Cell Immunotherapy Product Solution and Service
Table 21. Date of Enter into CAR T-Cell Immunotherapy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global CAR T-Cell Immunotherapy Market Size by Type (2016-2021) (US$ Million)
Table 24. Global CAR T-Cell Immunotherapy Revenue Market Share by Type (2016-2021)
Table 25. Global CAR T-Cell Immunotherapy Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global CAR T-Cell Immunotherapy Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global CAR T-Cell Immunotherapy Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global CAR T-Cell Immunotherapy Revenue Market Share by Application (2016-2021)
Table 29. Global CAR T-Cell Immunotherapy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global CAR T-Cell Immunotherapy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America CAR T-Cell Immunotherapy Market Size by Type (2016-2021) (US$ Million)
Table 32. North America CAR T-Cell Immunotherapy Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America CAR T-Cell Immunotherapy Market Size by Application (2016-2021) (US$ Million)
Table 34. North America CAR T-Cell Immunotherapy Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America CAR T-Cell Immunotherapy Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America CAR T-Cell Immunotherapy Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe CAR T-Cell Immunotherapy Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe CAR T-Cell Immunotherapy Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe CAR T-Cell Immunotherapy Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe CAR T-Cell Immunotherapy Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe CAR T-Cell Immunotherapy Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe CAR T-Cell Immunotherapy Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific CAR T-Cell Immunotherapy Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific CAR T-Cell Immunotherapy Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific CAR T-Cell Immunotherapy Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific CAR T-Cell Immunotherapy Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific CAR T-Cell Immunotherapy Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific CAR T-Cell Immunotherapy Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America CAR T-Cell Immunotherapy Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America CAR T-Cell Immunotherapy Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America CAR T-Cell Immunotherapy Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America CAR T-Cell Immunotherapy Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America CAR T-Cell Immunotherapy Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America CAR T-Cell Immunotherapy Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa CAR T-Cell Immunotherapy Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa CAR T-Cell Immunotherapy Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa CAR T-Cell Immunotherapy Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa CAR T-Cell Immunotherapy Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa CAR T-Cell Immunotherapy Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa CAR T-Cell Immunotherapy Market Size by Country (2022-2027) & (US$ Million)
Table 61. AbbVie Company Details
Table 62. AbbVie Business Overview
Table 63. AbbVie CAR T-Cell Immunotherapy Product
Table 64. AbbVie Revenue in CAR T-Cell Immunotherapy Business (2016-2021) & (US$ Million)
Table 65. AbbVie Recent Development
Table 66. Celgene Company Details
Table 67. Celgene Business Overview
Table 68. Celgene CAR T-Cell Immunotherapy Product
Table 69. Celgene Revenue in CAR T-Cell Immunotherapy Business (2016-2021) & (US$ Million)
Table 70. Celgene Recent Development
Table 71. Kite Pharma Company Details
Table 72. Kite Pharma Business Overview
Table 73. Kite Pharma CAR T-Cell Immunotherapy Product
Table 74. Kite Pharma Revenue in CAR T-Cell Immunotherapy Business (2016-2021) & (US$ Million)
Table 75. Kite Pharma Recent Development
Table 76. Oxford BioMedica Company Details
Table 77. Oxford BioMedica Business Overview
Table 78. Oxford BioMedica CAR T-Cell Immunotherapy Product
Table 79. Oxford BioMedica Revenue in CAR T-Cell Immunotherapy Business (2016-2021) & (US$ Million)
Table 80. Oxford BioMedica Recent Development
Table 81. Novartis Company Details
Table 82. Novartis Business Overview
Table 83. Novartis CAR T-Cell Immunotherapy Product
Table 84. Novartis Revenue in CAR T-Cell Immunotherapy Business (2016-2021) & (US$ Million)
Table 85. Novartis Recent Development
Table 86. Gilead Company Details
Table 87. Gilead Business Overview
Table 88. Gilead CAR T-Cell Immunotherapy Product
Table 89. Gilead Revenue in CAR T-Cell Immunotherapy Business (2016-2021) & (US$ Million)
Table 90. Gilead Recent Development
Table 91. Pfizer Company Details
Table 92. Pfizer Business Overview
Table 93. Pfizer CAR T-Cell Immunotherapy Product
Table 94. Pfizer Revenue in CAR T-Cell Immunotherapy Business (2016-2021) & (US$ Million)
Table 95. Pfizer Recent Development
Table 96. Cellectis Company Details
Table 97. Cellectis Business Overview
Table 98. Cellectis Revenue in CAR T-Cell Immunotherapy Business (2016-2021) & (US$ Million)
Table 99. Cellectis Recent Development
Table 100. Bellicum Company Details
Table 101. Bellicum Business Overview
Table 102. Bellicum CAR T-Cell Immunotherapy Product
Table 103. Bellicum Revenue in CAR T-Cell Immunotherapy Business (2016-2021) & (US$ Million)
Table 104. Bellicum Recent Development
Table 105. Mustang Bio Company Details
Table 106. Mustang Bio Business Overview
Table 107. Mustang Bio CAR T-Cell Immunotherapy Product
Table 108. Mustang Bio Revenue in CAR T-Cell Immunotherapy Business (2016-2021) & (US$ Million)
Table 109. Mustang Bio Recent Development
Table 110. CARsgen Therapeutics Company Details
Table 111. CARsgen Therapeutics Business Overview
Table 112. CARsgen Therapeutics CAR T-Cell Immunotherapy Product
Table 113. CARsgen Therapeutics Revenue in CAR T-Cell Immunotherapy Business (2016-2021) & (US$ Million)
Table 114. CARsgen Therapeutics Recent Development
Table 115. Xyphos Company Details
Table 116. Xyphos Business Overview
Table 117. Xyphos CAR T-Cell Immunotherapy Product
Table 118. Xyphos Revenue in CAR T-Cell Immunotherapy Business (2016-2021) & (US$ Million)
Table 119. Xyphos Recent Development
Table 120. Minerva Biotechnologies Company Details
Table 121. Minerva Biotechnologies Business Overview
Table 122. Minerva Biotechnologies CAR T-Cell Immunotherapy Product
Table 123. Minerva Biotechnologies Revenue in CAR T-Cell Immunotherapy Business (2016-2021) & (US$ Million)
Table 124. Minerva Biotechnologies Recent Development
Table 125. Adaptimmune Company Details
Table 126. Adaptimmune Business Overview
Table 127. Adaptimmune CAR T-Cell Immunotherapy Product
Table 128. Adaptimmune Revenue in CAR T-Cell Immunotherapy Business (2016-2021) & (US$ Million)
Table 129. Adaptimmune Recent Development
Table 130. Ziopharm Oncology Company Details
Table 131. Ziopharm Oncology Business Overview
Table 132. Ziopharm Oncology CAR T-Cell Immunotherapy Product
Table 133. Ziopharm Oncology Revenue in CAR T-Cell Immunotherapy Business (2016-2021) & (US$ Million)
Table 134. Ziopharm Oncology Recent Development
Table 135. Aurora Biopharma Company Details
Table 136. Aurora Biopharma Business Overview
Table 137. Aurora Biopharma CAR T-Cell Immunotherapy Product
Table 138. Aurora Biopharma Revenue in CAR T-Cell Immunotherapy Business (2016-2021) & (US$ Million)
Table 139. Aurora Biopharma Recent Development
Table 140. Creative Biolabs Company Details
Table 141. Creative Biolabs Business Overview
Table 142. Creative Biolabs CAR T-Cell Immunotherapy Product
Table 143. Creative Biolabs Revenue in CAR T-Cell Immunotherapy Business (2016-2021) & (US$ Million)
Table 144. Creative Biolabs Recent Development
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Global CAR T-Cell Immunotherapy Market Share by Type: 2020 VS 2027
Figure 2. Monotherapy Features
Figure 3. Combination Therapy Features
Figure 4. Global CAR T-Cell Immunotherapy Market Share by Application: 2020 VS 2027
Figure 5. Hematologic Malignancies Case Studies
Figure 6. Solid Malignancies Case Studies
Figure 7. CAR T-Cell Immunotherapy Report Years Considered
Figure 8. Global CAR T-Cell Immunotherapy Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global CAR T-Cell Immunotherapy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global CAR T-Cell Immunotherapy Market Share by Regions: 2020 VS 2027
Figure 11. Global CAR T-Cell Immunotherapy Market Share by Regions (2022-2027)
Figure 12. Global CAR T-Cell Immunotherapy Market Share by Players in 2020
Figure 13. Global Top CAR T-Cell Immunotherapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CAR T-Cell Immunotherapy as of 2020
Figure 14. The Top 10 and 5 Players Market Share by CAR T-Cell Immunotherapy Revenue in 2020
Figure 15. Global CAR T-Cell Immunotherapy Revenue Market Share by Type (2016-2021)
Figure 16. Global CAR T-Cell Immunotherapy Revenue Market Share by Type (2022-2027)
Figure 17. North America CAR T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America CAR T-Cell Immunotherapy Market Share by Type (2016-2027)
Figure 19. North America CAR T-Cell Immunotherapy Market Share by Application (2016-2027)
Figure 20. North America CAR T-Cell Immunotherapy Market Share by Country (2016-2027)
Figure 21. United States CAR T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada CAR T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe CAR T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe CAR T-Cell Immunotherapy Market Share by Type (2016-2027)
Figure 25. Europe CAR T-Cell Immunotherapy Market Share by Application (2016-2027)
Figure 26. Europe CAR T-Cell Immunotherapy Market Share by Country (2016-2027)
Figure 27. Germany CAR T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France CAR T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. CAR T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy CAR T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia CAR T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic CAR T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific CAR T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific CAR T-Cell Immunotherapy Market Share by Type (2016-2027)
Figure 35. Asia-Pacific CAR T-Cell Immunotherapy Market Share by Application (2016-2027)
Figure 36. Asia-Pacific CAR T-Cell Immunotherapy Market Share by Region (2016-2027)
Figure 37. China CAR T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan CAR T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea CAR T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia CAR T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India CAR T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia CAR T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America CAR T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America CAR T-Cell Immunotherapy Market Share by Type (2016-2027)
Figure 45. Latin America CAR T-Cell Immunotherapy Market Share by Application (2016-2027)
Figure 46. Latin America CAR T-Cell Immunotherapy Market Share by Country (2016-2027)
Figure 47. Mexico CAR T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil CAR T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa CAR T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa CAR T-Cell Immunotherapy Market Share by Type (2016-2027)
Figure 51. Middle East & Africa CAR T-Cell Immunotherapy Market Share by Application (2016-2027)
Figure 52. Middle East & Africa CAR T-Cell Immunotherapy Market Share by Country (2016-2027)
Figure 53. Turkey CAR T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia CAR T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE CAR T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. AbbVie Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2016-2021)
Figure 57. Celgene Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2016-2021)
Figure 58. Kite Pharma Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2016-2021)
Figure 59. Oxford BioMedica Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2016-2021)
Figure 60. Novartis Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2016-2021)
Figure 61. Gilead Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2016-2021)
Figure 62. Pfizer Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2016-2021)
Figure 63. Cellectis Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2016-2021)
Figure 64. Bellicum Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2016-2021)
Figure 65. Mustang Bio Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2016-2021)
Figure 66. CARsgen Therapeutics Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2016-2021)
Figure 67. Xyphos Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2016-2021)
Figure 68. Minerva Biotechnologies Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2016-2021)
Figure 69. Adaptimmune Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2016-2021)
Figure 70. Ziopharm Oncology Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2016-2021)
Figure 71. Aurora Biopharma Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2016-2021)
Figure 72. Creative Biolabs Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed

以下、関連資料のご紹介

世界の樹状細胞癌ワクチン免疫療法市場規模・現状・予測（2021年-2027年）

Global Dendritic Cell Cancer Vaccine Immunotherapy Market Size, Status and Forecast 2021-2027
QFJ1-5694 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、樹状細胞癌ワクチン免疫療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（プロベンジ、アプセデン、CreaVax、その他）、用途別市場規模（小児科、成人用）、主要地域別市場規模（北米、アメリカ、欧州、...

世界の細胞ベース免疫療法市場規模・現状・予測（2021年-2027年）

Global Cell-Based Immunotherapy Market Size, Status and Forecast 2021-2027
QFJ1-3992 2021年6月 118Pages
QYResearch社発行の本調査レポートでは、細胞ベース免疫療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（自己細胞免疫療法、CAR（キメラ抗原受容体）T細胞療法、樹状細胞ベースワクチン療法）、用途別市場規模（病院、診療所、外来外科センター、...

世界の血液がん遺伝子改変免疫療法市場規模・現状・予測（2021年-2027年）

Global Gene Modifying Immunotherapy for Blood Cancer Market Size, Status and Forecast 2021-2027
QFJ1-4247 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、血液がん遺伝子改変免疫療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（CAR T細胞療法、TCRT細胞療法）、用途別市場規模（急性リンパ性白血病、慢性リンパ性白血病、B細胞リンパ腫、多発性骨髄腫、...

世界の舌下アレルギー免疫療法市場規模・現状・予測（2021年-2027年）

Global Sublingual Allergy Immunotherapy Market Size, Status and Forecast 2021-2027
QFJ1-4913 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、舌下アレルギー免疫療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（錠剤、点滴）、用途別市場規模（鼻炎、喘息、湿疹、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、イン...

世界のがん免疫療法市場規模・現状・予測（2021年-2027年）

Global Cancer Immunotherapy Market Size, Status and Forecast 2021-2027
QFJ1-5642 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、がん免疫療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（モノクローナル抗体、免疫チェックポイント阻害剤、免疫系モジュレーター、癌ワクチン）、用途別市場規模（肺がん、乳がん、結腸直腸がん、黒色腫、前...

世界のPD-1＆PD-L1免疫療法市場規模・現状・予測（2021年-2027年）

Global PD-1 and PD-L1 Immunotherapy Market Size, Status and Forecast 2021-2027
QFJ1-4668 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、PD-1＆PD-L1免疫療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PD-1阻害剤、PD-L1阻害剤）、用途別市場規模（固形腫瘍、血液関連腫瘍）、主要地域別市場規模（北米、アメリカ、欧州、アジ...

世界のT細胞急性リンパ芽球性白血病治療市場規模・現状・予測（2021年-2027年）

Global T-cell Acute Lymphoblastic Leukemia Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4935 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、T細胞急性リンパ芽球性白血病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、放射線療法、骨髄移植、標的療法、免疫療法）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、...

世界の線維形成性小円形細胞腫瘍治療市場規模・現状・予測（2021年-2027年）

Global Desmoplastic Small Round Cell Tumor Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4116 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、線維形成性小円形細胞腫瘍治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（免疫療法、外科手術、化学療法、放射線療法）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州...

世界のBCL-2（B細胞リンパ腫2）阻害剤市場規模・現状・予測（2021年-2027年）

Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Size, Status and Forecast 2021-2027
QFJ1-5611 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、BCL-2（B細胞リンパ腫2）阻害剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（併用療法、単剤療法）、用途別市場規模（がん、自己免疫疾患、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア...

世界の腎細胞がん臨床試験パイプライン市場規模・現状・予測（2021年-2027年）

Global Renal Cell Carcinoma Clinical Trial Pipeline Market Size, Status and Forecast 2021-2027
QFJ1-4808 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、腎細胞がん臨床試験パイプラインの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（標的療法、免疫療法）、用途別市場規模（病院、研究所、商業、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本...

世界の細胞ベース免疫療法市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Cell-Based Immunotherapy Market The global Cell-Based Immunotherapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the …
世界の樹状細胞癌ワクチン免疫療法市場規模・現状・予測（2021年-2027年） Dendritic cells (DCs) are one of the major antigen-presenting cells found in lymphoid organs. Main function of the dendritic cells is antigen display and activation of T-cells. Antigen display presents the identity of pathogen to T-cells for their identification and elimination from the body. These …
世界の血液がん遺伝子改変免疫療法市場規模・現状・予測（2021年-2027年） Genetic modification immunotherapy for blood cancer is a technique that involves genetic modification of immune system T cells.It allows T cells to recognize weakly expressed antigens in the blood or other organs of the body, such as tumor cells.This form of immunotherapy can be divided into two typ…
T細胞免疫療法のグローバル市場調査 2019年 The global T-Cell Immunotherapy market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on T-Cell Immunotherapy volume and value at global level, regional level and company level. From a global perspective, th…
T細胞免疫療法のグローバル市場調査 2019年 The global T-Cell Immunotherapy market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on T-Cell Immunotherapy volume and value at global level, regional level and company level. From a global perspective, th…